Share on StockTwits

Allergan Inc, trying to fend off a hostile takeover bid from Valeant Pharmaceuticals International Inc, has stacked the odds against a special shareholders meeting. Pershing Square Capital Management, which is led by Bill Ackman, is attempting to muster at least 25 percent support of Allergan shares to hold a special meeting that could replace most of the Botox anti-wrinkle injection maker’s board, which has refused to negotiate with Valeant. In a webcast for investors, Ackman said Allergan’s rules for special meetings were designed to stop them from occurring. Ackman added that shareholders must hold their stock through the date of the special meeting for them to count.



“Ackman: Allergan Rules For Shareholder Meetings Too Onerous” is categorized as “business”. This video was licensed from Grab Networks. For additional video content, click the “video” tab at the top of this page.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.